When was Adherium founded?

Adherium was founded in 2001 and raised its 1st funding round 15 years after it was founded.

Where is Adherium located?

Adherium is headquartered in Auckland, New Zealand. It is registered at Level 2, 63 Albert Street, Auckland, 1010, New Zealand.

Who is the current CEO of Adherium?

Garth Sutherland and Paul Mastoridis s of Adherium.

Which legal entities is Adherium associated with?

Adherium is associated with Adherium (nz) Limited and 2 others.

How many employees does Adherium have?

As of Sep 30, 2026, the latest employee count at Adherium is 35.

Is Adherium a funded company?

Adherium is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Jul 20, 2016.

When was the latest funding round of Adherium?

Adherium's latest funding was a $***** Post IPO round on Oct 26, 2020, with participation from 0 investor.

Where does Adherium rank among its competitors?

Adherium ranks 1st amongst 6 active competitors, of which 2 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Tabiat Care, which secured an undisclosed amount in Jan, 2023.

Who are the top competitors of Adherium?

Adherium's top competitors include Epital Health, Tabiat Care and AIRx Health. Among them, Tabiat Care secured the most recent funding round in January, 2023.

Adherium - 2026 Company Profile, Team, Funding & Competitors

Company Details

Adherium is a medical device company that manufactures and commercializes smart inhalers to check medication adherence in Asthma, COPD, and other chronic disease patients. Adherium’s proprietary platform, Smartinhaler, comprising medical devices, apps, and cloud-based management software. Sends data on when the medication was taken to mobile devices and desktop computers via Bluetooth. Also, transmits audio and visual reminders to the patient when they miss a critical dose of preventative medication. The platform is designed to help patients, caregivers, and physicians remotely monitor and manage patients’ adherence to their medication. The devices have both a CE Mark and FDA 510(k) clearance. Adherium has partnered with AstraZeneca to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma. Collaborates with research groups and pharmaceutical companies.

Website: adherium.com
Social
Email ID: *****@adherium.com
Registered Address: Level 2, 63 Albert Street, Auckland, 1010, New Zealand

Key Metrics

Founded Year

2001

Location

Auckland, New Zealand

Stage

Public

Latest Funding Round

Post IPO, Oct 26, 2020, $*****

Investors

Fidelity Investments & 5 more

Ranked

1^st among 6 active competitors

Employee Count

35 as on Sep 30, 2026

Similar Companies

Epital Health & 5 more

Exit Details

Public

View Adherium's full profile

Adherium is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
Adherium (nz) Limited CIN: 1155872 , New Zealand, Active	Aug 14, 2001	-	-
ADHERIUM LIMITED CIN: 605352510 , Australia, Active	Apr 16, 2015	-	-
ADHERIUM EUROPE LTD CIN: 10071813 , United Kingdom, Active	Mar 17, 2016	-	-

Adherium got listed on Aug 26, 2015.

Click here to take a look at Adherium's IPO in detail

Adherium has raised funding over 3 rounds. Its first funding round was on Jul 20, 2016. Adherium has 6 institutional investors.

Here is the list of recent funding rounds of Adherium:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 26, 2020	9147492	Post IPO	7311860	9266697	6770503	7043324
Aug 22, 2019	9156645	Conventional Debt	2899987	4700683	9255496	7267531
Jul 20, 2016	2662571	Post IPO	1525338	4533350	8047630	Fidelity Investments

Access funding benchmarks and valuations. Sign up today!

View details of Adherium's funding rounds and investors

The founders of Adherium is Garth Sutherland. Paul Mastoridis is the CEO of Adherium.

Here are the details of Adherium's key team members:

Garth Sutherland: Former Founder & CEO of Adherium and founder of 1 other company.
Paul Mastoridis: CEO of Adherium.
Contact Info: 1 email address

View details of Adherium's Founder profiles and Board Members

Adherium's employee count trend

Adherium has 35 employees as of Sep 26. Here is Adherium's employee count trend over the years:

Uncover Adherium's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Adherium include Epital Health, Tabiat Care and AIRx Health. Here is the list of Top 10 competitors of Adherium, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Adherium 2001, Auckland (New Zealand), Public	Smart inhaler for checking medication adherence	-	Fidelity Investments, BioScience Managers ... & 4 others	57/100
2nd	Epital Health 2019, Soborg (Denmark), Unfunded	Provider of remote EEG monitoring system to detect lung fucntions	-	-	32/100
3rd	Tabiat Care Toronto (Canada), Seed	Provider of AI based platform for remote monitoring for COPD	-	Right Side Capital Management, UTEST	29/100
4th	AIRx Health 2018, Cupertino (United States), Seed	Limited information available	$150K	Y Combinator, Pioneer Fund & 3 others	25/100
5th	Medvoice Pittsburgh (United States), Unfunded	MedVoice.AI	-	-	24/100
6th	PulManage 2020, Chapin (United States), Unfunded	Provider of a remote patient monitoring platform to manage chronic lung diseases	-	-	18/100
7th	Oxii Labs 2018, United States, Deadpooled	Provider of a software integrated device for the treatment of COPD and asthma	-	The Forge	16/100